Article

KAIST has introduced 'AGCL Powder,' a hemostatic agent that forms a hydrogel barrier in just one second upon application to wounds. Composed of biocompatible materials, it absorbs over 725% of its weight in blood and features a low hemolysis rate and significant antibacterial properties, making it suitable for military and emergency medical use. Developed with insights from Army major Park Gyu-soon, the powder aims to reduce casualties in combat and enhance civilian medical care.